APA

Lanzetta G., Campanella C., Rozzi A., Nappa M., Costa A., Fedele F., Innocenzi G., Gagliardi F. M., Salvati M., Minniti G., Frati A., Frati L. & Vecchione A. (20040405). Temozolomide in radio-chemotherapy combined treatment for newly-diagnosed glioblastoma multiforme: phase II clinical trial. : Anticancer research.

Chicago

Lanzetta G, Campanella C, Rozzi A, Nappa M, Costa A, Fedele F, Innocenzi G, Gagliardi F M, Salvati M, Minniti G, Frati A, Frati L and Vecchione A. 20040405. Temozolomide in radio-chemotherapy combined treatment for newly-diagnosed glioblastoma multiforme: phase II clinical trial. : Anticancer research.

Harvard

Lanzetta G., Campanella C., Rozzi A., Nappa M., Costa A., Fedele F., Innocenzi G., Gagliardi F. M., Salvati M., Minniti G., Frati A., Frati L. and Vecchione A. (20040405). Temozolomide in radio-chemotherapy combined treatment for newly-diagnosed glioblastoma multiforme: phase II clinical trial. : Anticancer research.

MLA

Lanzetta G, Campanella C, Rozzi A, Nappa M, Costa A, Fedele F, Innocenzi G, Gagliardi F M, Salvati M, Minniti G, Frati A, Frati L and Vecchione A. Temozolomide in radio-chemotherapy combined treatment for newly-diagnosed glioblastoma multiforme: phase II clinical trial. : Anticancer research. 20040405.